Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes
N Engl J Med
.
2021 Mar 18;384(11):e42.
doi: 10.1056/NEJMc2036175.
Author
Donald Baumstein
1
Affiliation
1
Metropolitan Hospital Center, New York, NY donald.baumstein@nychhc.org.
PMID:
33730465
DOI:
10.1056/NEJMc2036175
No abstract available
Publication types
Letter
Comment
MeSH terms
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Humans
Naphthyridines
Renal Insufficiency, Chronic* / complications
Substances
Naphthyridines
finerenone